158 related articles for article (PubMed ID: 30920030)
1. Molecular evidence supporting the precursor nature of atypical adenomatous hyperplasia of the prostate.
Cheng L; Montironi R; Davidson DD; Wang M; Lopez-Beltran A; Zhang S
Mol Carcinog; 2019 Jul; 58(7):1272-1278. PubMed ID: 30920030
[TBL] [Abstract][Full Text] [Related]
2. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
[TBL] [Abstract][Full Text] [Related]
3. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
Qian J; Bostwick DG
Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.
Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z
Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of prostate tumour overexpressed 1 (PTOV1) in atypical adenomatous hyperplasia (AAH) of the prostate: additional evidence linking (AAH) to adenocarcinoma.
Mazzucchelli R; Scarpelli M; Barbisan F; Santinelli A; Lopez-Beltran A; Cheng L; Montironi R
Cell Oncol (Dordr); 2013 Feb; 36(1):37-42. PubMed ID: 23132460
[TBL] [Abstract][Full Text] [Related]
6. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
7. Comparison of monoclonal antibody (P504S) and polyclonal antibody to alpha methylacyl-CoA racemase (AMACR) in the work-up of prostate cancer.
Kunju LP; Chinnaiyan AM; Shah RB
Histopathology; 2005 Dec; 47(6):587-96. PubMed ID: 16324196
[TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.
Ananthanarayanan V; Deaton RJ; Yang XJ; Pins MR; Gann PH
Prostate; 2005 Jun; 63(4):341-6. PubMed ID: 15602744
[TBL] [Abstract][Full Text] [Related]
9. Premalignant lesions of prostate and their association with nodular hyperplasia and carcinoma prostate.
Rekhi B; Jaswal TS; Arora B
Indian J Cancer; 2004; 41(2):60-5. PubMed ID: 15318010
[TBL] [Abstract][Full Text] [Related]
10. Prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia. Relationship to pathologic parameters, volume and spatial distribution of carcinoma of the prostate.
Sakr WA; Grignon DJ
Anal Quant Cytol Histol; 1998 Oct; 20(5):417-23. PubMed ID: 9801760
[TBL] [Abstract][Full Text] [Related]
11. Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia.
Sakr WA; Partin AW
Urology; 2001 Apr; 57(4 Suppl 1):115-20. PubMed ID: 11295607
[TBL] [Abstract][Full Text] [Related]
12. MAGI-2 Is a Sensitive and Specific Marker of Prostatic Adenocarcinoma: A Comparison With AMACR.
Goldstein J; Goyal R; Roland JT; Gellert LL; Clark PE; Hameed O; Giannico GA
Am J Clin Pathol; 2016 Sep; 146(3):294-302. PubMed ID: 27543977
[TBL] [Abstract][Full Text] [Related]
13. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma.
Helpap B; Bonkhoff H; Cockett A; Montironi R; Troncoso P; Waters D; Bostwick D
Pathologica; 1997 Jun; 89(3):288-300. PubMed ID: 9270265
[TBL] [Abstract][Full Text] [Related]
14. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia.
Wu CL; Yang XJ; Tretiakova M; Patton KT; Halpern EF; Woda BA; Young RH; Jiang Z
Hum Pathol; 2004 Aug; 35(8):1008-13. PubMed ID: 15297968
[TBL] [Abstract][Full Text] [Related]
15. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
Leav I; McNeal JE; Ho SM; Jiang Z
Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic limits in precursor lesions of prostatic cancer.
Algaba F; Trias I
Eur Urol; 1996; 30(2):212-21. PubMed ID: 8875203
[TBL] [Abstract][Full Text] [Related]
17. The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma. An update.
Helpap BG; Bostwick DG; Montironi R
Virchows Arch; 1995; 426(5):425-34. PubMed ID: 7543337
[TBL] [Abstract][Full Text] [Related]
18. Cell kinetic studies on prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (AAH) of the prostate.
Helpap B
Pathol Res Pract; 1995 Sep; 191(9):904-7. PubMed ID: 8606872
[TBL] [Abstract][Full Text] [Related]
19. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
Stewart J; Fleshner N; Cole H; Sweet J
J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
[TBL] [Abstract][Full Text] [Related]
20. Atypical adenomatous hyperplasia of the prostate. Relationship with carcinoma in 217 whole-mount radical prostatectomies.
Bostwick DG; Qian J
Am J Surg Pathol; 1995 May; 19(5):506-18. PubMed ID: 7537024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
